ArticleJournal of gastrointestinal oncology2022

Efficacy and safety of sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a two-center study in China.

Shao-Hua Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.